Related Experiment Videos
Tumor inhibition by effector cells cultured from progressing sarcomas
Immunological Communications
|January 1, 1977
Summary
Cytotoxic lymphoid cells can inhibit tumor growth in guinea pigs. However, their effectiveness depends on dosage and administration route, suggesting a complex tumor rejection mechanism beyond simple killer-target cell interaction.
Area of Science:
- Immunology
- Oncology
- Cell Biology
Background:
- Investigating the role of cytotoxic lymphoid cells in tumor immunity.
- Understanding the mechanisms of tumor rejection in vivo.
Purpose of the Study:
- To determine the effect of cytotoxic lymphoid cells on tumor growth in syngeneic guinea pig models.
- To explore the influence of effector cell dosage and administration route on tumor suppression.
Main Methods:
- Primary cultures of antigenic sarcoma from strain 13 guinea pigs.
- In vivo studies using normal and X-irradiated syngeneic recipients.
- Administration of varying doses of cytotoxic effector cells mixed with tumor cells.
Main Results:
- Low doses of effector cells mixed with tumor cells inhibited or rejected lethal tumor inocula in normal recipients.
- High doses of effector cells showed significant tumor inhibition in X-irradiated recipients.
- Sonication of effector cells abolished their tumor-suppressing effect, and animals rejecting tumors developed immunity to subsequent challenges.
Conclusions:
- Tumor rejection in vivo is a complex phenomenon not solely dependent on killer-target cell interaction.
- Cytotoxic lymphoid cell efficacy is influenced by dose, administration route, and recipient's physiological state.
- Further research is needed to elucidate the intricate mechanisms underlying tumor rejection and immunity.